[HTML][HTML] Safety and efficacy of NVX-CoV2373 Covid-19 vaccine
…, G Albert, I Cho, F Dubovsky, G Glenn… - … England Journal of …, 2021 - Mass Medical Soc
Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…
[HTML][HTML] Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
…, A Robertson, S Neal, I Cho, GM Glenn… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
[HTML][HTML] Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled …
…, R Roberts, I Valéa, H Sorgho, N Williams, G Glenn… - The Lancet, 2021 - thelancet.com
Background Stalled progress in controlling Plasmodium falciparum malaria highlights the
need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine …
need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine …
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Vaccine efforts to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is responsible for the current coronavirus disease 2019 (COVID-19) pandemic, are …
which is responsible for the current coronavirus disease 2019 (COVID-19) pandemic, are …
[HTML][HTML] Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised …
…, I Valéa, H Sorgho, N Williams, G Glenn… - The Lancet Infectious …, 2022 - thelancet.com
Background Malaria is a leading cause of morbidity and mortality worldwide. We previously
reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified …
reported the efficacy of the R21/Matrix-M malaria vaccine, which reached the WHO-specified …
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a …
…, A Robertson, F Dubovsky, G Glenn… - The Lancet …, 2022 - thelancet.com
Background The safety and immunogenicity profile of COVID-19 vaccines when administered
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
[HTML][HTML] Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico
…, K Smith, W Woo, I Cho, GM Glenn… - … England Journal of …, 2022 - Mass Medical Soc
Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
[HTML][HTML] Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
…, P Griffin, B Wilkinson, GM Glenn - New england journal …, 2020 - Mass Medical Soc
Background NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
Cold water fish gelatin films: Effects of cross-linking on thermal, mechanical, barrier, and biodegradation properties
…, H Jafri, R Narayan, SH Imam, GM Glenn… - European Polymer …, 2008 - Elsevier
Gelatin was extracted from Alaska pollock (Theragra chalcogramma) and Alaska pink salmon
(Oncorhynchus gorbuscha) skins and cast into films. The fish gelatin films’ tensile, thermal, …
(Oncorhynchus gorbuscha) skins and cast into films. The fish gelatin films’ tensile, thermal, …
Efficacy of mRNA-1273 and Novavax ancestral or BA. 1 spike booster vaccines against SARS-CoV-2 BA. 5 infection in nonhuman primates
…, N Patel, M Guebre-Xabier, G Smith, G Glenn… - Science …, 2023 - science.org
Omicron SARS-CoV-2 variants escape vaccine-induced neutralizing antibodies and cause
nearly all current COVID-19 cases. Here, we compared the efficacy of three booster vaccines …
nearly all current COVID-19 cases. Here, we compared the efficacy of three booster vaccines …